Michael Blackman, MD, MBA

Charlotte, North Carolina, United States Contact Info
1K followers 500+ connections

Join to view profile

About

I’m a proven problem solver and approachable collaborative leader, possessing an uncommon…

Activity

Join now to see all activity

Experience & Education

  • Greenway Health

View Michael’s full experience

See their title, tenure and more.

or

By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.

Licenses & Certifications

Publications

  • Prescribers' expectations and barrier to electronic prescribing of controlled substances

    Journal of the American Medical Informatics Association

    Abstract
    Objective
    To better understand barriers associated with the adoption and use of electronic prescribing of controlled substances (EPCS), a practice recently established by US Drug Enforcement Administration regulation.

    Materials and methods
    Prescribers of controlled substances affiliated with a regional health system were surveyed regarding current electronic prescribing (e-prescribing) activities, current prescribing of controlled substances, and expectations and…

    Abstract
    Objective
    To better understand barriers associated with the adoption and use of electronic prescribing of controlled substances (EPCS), a practice recently established by US Drug Enforcement Administration regulation.

    Materials and methods
    Prescribers of controlled substances affiliated with a regional health system were surveyed regarding current electronic prescribing (e-prescribing) activities, current prescribing of controlled substances, and expectations and barriers to the adoption of EPCS.

    Results
    246 prescribers (response rate of 64%) represented a range of medical specialties, with 43.1% of these prescribers current users of e-prescribing for non-controlled substances. Reported issues with controlled substances included errors, pharmacy call-backs, and diversion; most prescribers expected EPCS to address many of these problems, specifically reduce medical errors, improve work flow and efficiency of practice, help identify prescription diversion or misuse, and improve patient treatment management. Prescribers expected, however, that it would be disruptive to practice, and over one-third of respondents reported that carrying a security authentication token at all times would be so burdensome as to discourage adoption.

    Discussion
    Although adoption of e-prescribing has been shown to dramatically reduce medication errors, challenges to efficient processes and errors still persist from the perspective of the prescriber, that may interfere with the adoption of EPCS. Most prescribers regarded EPCS security measures as a small or moderate inconvenience (other than carrying a security token), with advantages outweighing the burden.

    Conclusion
    Prescribers are optimistic about the potential for EPCS to improve practice, but view certain security measures as a burden and potential barrier.

    Keywords: Medications, pharmacy, electronic prescribing, controlled substances, electronic prescribing, EPCS

    Other authors
    • Cindy Parks Thomas, Meelee Kim, Ann McDonald, Peter Kreiner, Stephen J Kelleher, Jr,
    • Peter N Kaufman, Grant M Carrow
    See publication

Recommendations received

More activity by Michael

View Michael’s full profile

  • See who you know in common
  • Get introduced
  • Contact Michael directly
Join to view full profile

Explore collaborative articles

We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.

Explore More

Add new skills with these courses